During the past decade, Josha Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Josha Research" #1 sponsor was "Pfizer" with 5 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "Kirby Institute" with 2 trials sponsored and "Wits Health Consortium (Pty) Ltd" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Josha Research" #1 collaborator was "Bio Analytical Research Corporation" with 2 trials as a collaborator, "BioVac" with 2 trials as a collaborator, "Biocair" with 2 trials as a collaborator, "Clinical Laboratory Services" with 2 trials as a collaborator and "Dis-Chem Pharmacy" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Josha Research" are "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "HIV" (2 trials), "Venous Leg Ulcer" (2 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Josha Research" in a lesser frequency.

Most popular intervention types in "Josha Research" are "Drug" (16 trials), "Biological" (11 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Profore" (2 trials), "RSVpreF" (2 trials), "Rilpivirine" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Josha Research" are 26 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Josha Research". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Josha Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Josha Research, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".